BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35897807)

  • 1. Integrated CRISPR-Cas9 System-Mediated Knockout of IFN-γ and IFN-γ Receptor 1 in the Vero Cell Line Promotes Viral Susceptibility.
    Kim S; Nowakowska A; Kim YB; Shin HY
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta interferon and gamma interferon synergize to block viral DNA and virion synthesis in herpes simplex virus-infected cells.
    Pierce AT; DeSalvo J; Foster TP; Kosinski A; Weller SK; Halford WP
    J Gen Virol; 2005 Sep; 86(Pt 9):2421-2432. PubMed ID: 16099899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RIG-I is responsible for activation of type I interferon pathway in Seneca Valley virus-infected porcine cells to suppress viral replication.
    Li P; Zhang X; Cao W; Yang F; Du X; Shi Z; Zhang M; Liu X; Zhu Z; Zheng H
    Virol J; 2018 Oct; 15(1):162. PubMed ID: 30352599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The synergistic effect of IFN-alpha and IFN-gamma against HSV-2 replication in Vero cells is not interfered by the plant antiviral 1-cinnamoyl-3, 11-dihydroxymeliacarpin.
    Petrera E; Coto CE
    Virol J; 2006 Jun; 3():45. PubMed ID: 16772029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of the Nuclear Protein RTF2 Enhances Influenza Virus Replication.
    Chia BS; Li B; Cui A; Eisenhaure T; Raychowdhury R; Lieb D; Hacohen N
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32878895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type I interferon production during herpes simplex virus infection is controlled by cell-type-specific viral recognition through Toll-like receptor 9, the mitochondrial antiviral signaling protein pathway, and novel recognition systems.
    Rasmussen SB; Sørensen LN; Malmgaard L; Ank N; Baines JD; Chen ZJ; Paludan SR
    J Virol; 2007 Dec; 81(24):13315-24. PubMed ID: 17913820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockout of IRF3 and IRF7 genes by CRISPR/Cas9 technology enhances porcine virus replication in the swine testicular (ST) cell line.
    Sun X; Wang J; Mou C; Shi K; Bao W; Chen Z
    Biotechnol J; 2024 Jan; 19(1):e2300389. PubMed ID: 38047496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Casein Kinase 1α Mediates the Degradation of Receptors for Type I and Type II Interferons Caused by Hemagglutinin of Influenza A Virus.
    Xia C; Wolf JJ; Vijayan M; Studstill CJ; Ma W; Hahm B
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29343571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increase of viral hemorrhagic septicemia virus growth by knockout of IRF9 gene in Epithelioma papulosum cyprini cells.
    Kim MS; Shin MJ; Kim KH
    Fish Shellfish Immunol; 2018 Dec; 83():443-448. PubMed ID: 30244086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immediate-early protein, ICP0, is essential for the resistance of herpes simplex virus to interferon-alpha/beta.
    Härle P; Sainz B; Carr DJ; Halford WP
    Virology; 2002 Feb; 293(2):295-304. PubMed ID: 11886249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elimination of GPR146-mediated antiviral function through IRF3/HES1-signalling pathway.
    Huang H; Zhang N; Xiong Q; Chen R; Zhang C; Wang N; Wang L; Ren H; Liu M; Qian M; Du B
    Immunology; 2017 Sep; 152(1):102-114. PubMed ID: 28464285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Independent and cooperative antiviral actions of beta interferon and gamma interferon against herpes simplex virus replication in primary human fibroblasts.
    Peng T; Zhu J; Hwangbo Y; Corey L; Bumgarner RE
    J Virol; 2008 Feb; 82(4):1934-45. PubMed ID: 18057251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herpes simplex virus type 2 virion host shutoff protein regulates alpha/beta interferon but not adaptive immune responses during primary infection in vivo.
    Murphy JA; Duerst RJ; Smith TJ; Morrison LA
    J Virol; 2003 Sep; 77(17):9337-45. PubMed ID: 12915549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variation in interferon sensitivity and induction among strains of eastern equine encephalitis virus.
    Aguilar PV; Paessler S; Carrara AS; Baron S; Poast J; Wang E; Moncayo AC; Anishchenko M; Watts D; Tesh RB; Weaver SC
    J Virol; 2005 Sep; 79(17):11300-10. PubMed ID: 16103182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-beta and interferon-gamma synergistically inhibit the replication of severe acute respiratory syndrome-associated coronavirus (SARS-CoV).
    Sainz B; Mossel EC; Peters CJ; Garry RF
    Virology; 2004 Nov; 329(1):11-7. PubMed ID: 15476870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Molecular Mechanism of Herpes Simplex Virus 1 UL31 in Antagonizing the Activity of IFN-β.
    Gong L; Ou X; Hu L; Zhong J; Li J; Deng S; Li B; Pan L; Wang L; Hong X; Luo W; Zeng Q; Zan J; Peng T; Cai M; Li M
    Microbiol Spectr; 2022 Feb; 10(1):e0188321. PubMed ID: 35196784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR-Cas- induced IRF3 and MAVS knockouts in a salmonid cell line disrupt PRR signaling and affect viral replication.
    van der Wal YA; Nordli H; Akandwanaho A; Greiner-Tollersrud L; Kool J; Jørgensen JB
    Front Immunol; 2023; 14():1214912. PubMed ID: 37588594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antiviral efficacy of the murine alpha-1 interferon transgene against ocular herpes simplex virus type 1 requires the presence of CD4(+), alpha/beta T-cell receptor-positive T lymphocytes with the capacity to produce gamma interferon.
    Carr DJ; Noisakran S
    J Virol; 2002 Sep; 76(18):9398-406. PubMed ID: 12186922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-translational modification of the interferon-gamma receptor alters its stability and signaling.
    Londino JD; Gulick DL; Lear TB; Suber TL; Weathington NM; Masa LS; Chen BB; Mallampalli RK
    Biochem J; 2017 Oct; 474(20):3543-3557. PubMed ID: 28883123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From functional genomics of vero cells to CRISPR-based genomic deletion for improved viral production rates.
    Sène MA; Xia Y; Kamen AA
    Biotechnol Bioeng; 2022 Oct; 119(10):2794-2805. PubMed ID: 35869699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.